BioInnovation Institute

The BioInnovation Institute (BII) is an international, independent commercial foundation based in Copenhagen, Denmark, that functions as an incubator and accelerator for science-based innovation. Established by the Novo Nordisk Foundation, BII provides a comprehensive support platform for early-stage start-ups and researchers within the fields of human health, planetary health, and societal resilience. The institute operates through structured programs—such as Bio Studio, Venture Lab, and Quantum Lab—that offer a combination of non-dilutive funding, plug-and-play laboratory and office infrastructure, business development guidance, and access to an international network of mentors and investors to help translate academic research into commercial ventures.

By serving as a bridge between high-level scientific research and the marketplace, BII plays a critical role in addressing gaps in the innovation ecosystem, where breakthrough projects often fail due to lack of resources or expertise. For entrepreneurs and academic partners, BII offers the necessary capital and professional support to mature projects to the point of investment readiness. The effectiveness of this model is evidenced by the significant external funding attracted by its alumni companies and the establishment of new products in the market, ultimately aiming to transform scientific potential into tangible solutions that benefit global welfare and economic growth.